Replies to post #5216 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>It would be better if Jim Cramer got behind GTCB instead.<

It would help in the short run but it would probably have no lasting effect. Barron’s recently presented empirical data that the Cramer Effect is short-lived and shorting Cramer’s picks for a month or so has been a winning strategy.